Log In
Print
BCIQ
Print
Print this Print this
 

Pexa-Vec, pexastimogene devacirepvec (JX-594, TG6006)

Also known as: JX-5940TG6006

  Manage Alerts
Collapse Summary General Information
Company SillaJen Biotherapeutics Inc.
DescriptionRecombinant vaccinia virus (addition of GM-CSF and deletion of thymidine kinase)
Molecular Target
Mechanism of Action 
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today